Items in cart [0] Questions? Call 888-624-8373

PAPERBACK list:$29.50 Web:$26.55 add to cart PDF BOOK your price: $23.00 add to cart Rights & Permissions Free Resources PDF EXECUTIVE SUMMARY Display this book on your site! Related Titles Catalyzing Inquiry at the Interface of Computing and Biology Reaping the Benefits of Genomic and Proteomic Research: Intellectual Property Rights, Innovation, and Public Health Other Related Titles Mapping and Sequencing the Human Genome (1988) Commission on Life Sciences (CLS) Web Search Builder Use this book's key terms to search within this book, across our collection, or across the Web. Skim This Chapter Skim this chapter and use this chapter's key terms to search within this book. Reference Finder Paste in your own text to find books that relate to your topic. Page 111   E-mail  Facebook  Digg  Stumble  Twitter More Page 111 Front Matter (R1-R12) 1. Executive Summary (1-11) 2. Introduction (12-25) 3. Implications for Medicine and Science (26-33) 4. Mapping (34-55) 5. Sequencing (56-74) 6. The Collection, Analysis, and Distribution of Information and Materials (75-85) 7. Implementation and Management Strategies (86-98) 8. Implications for Society (99-104) Appendix A. Glossary (105-107) Appendix B. Curricula Vitae of Committee Members (108-110) Appendix C. Invited Speakers at Committee Meetings (111-112) Index (113-116)

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 111
APPENDIX Invited Speakers at Committee Meetings HOWARD BlLOFSKY, Bolt Beranek and Newman Inc. GEORGE CAHILL, Howard Hughes Medical Institute ELLSON CHEN, Genentech ROBERT COOK-DEEGAN, Office of Technology Assessment GEORGE CHURCH, Harvard University KAY E. DAVIES, University of Oxford RONALD W. DAVIS, Stanford University School of Medicine HELEN DONIS-KELLER, Collaborative Research, Inc. ARGIRIS EFSTRADIATIS, Columbia University College of Physicians and Surgeons DAVID GEORGE, National Biomedical Research Foundation Georgetown University Medical Center JAMES GUSELLA, Massachusetts General Hospital PATRICIA HOBEN, Office of Technology Assessment RUTH KIRSCHSTEIN, National Institute of General Medical Sciences/National Institutes of Health ERIC LANDER, Whitehead Institute for Biological Research and Harvard University DANIEL MASYS, National Library of Medicine/National Institutes of Health DAVID PATTERSON, Eleanor Roosevelt Institute for Cancer Research, Inc. DAVID SMITH, Health Effects Research Division, U.S. Department of Energy

OCR for page 112
7J2 ALAN SPRADLING, Carnegie Institute JE^N WE!SSENBACH, Inshtutc Pasteur RAY WHITE, Howard Hughes Medical Institute, University of Utab JOHN C. WOOLEY, Biological Instrumentabon Programs Nabona1 Science Foundadon JAMES WY~GA^RDEN, National Institutes of Health

Representative terms from entire chapter:

howard hughes